From Product to Platform: Henlius’ Practices & Progress in ADC to Address Unmet Medical Needs

Time: 9:00 am
day: Day One


  • Review how ADC is a strategic R&D field of Henlius based on its 13+ year antibody capabilities and integrated R&D platform
  • Explore the highlights of ADC assets' progress in clinical and pre-clinical stages
  • Learn how Henlius is dedicated in building ADC platform – “Hanjugator”